Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging

Journal of Nuclear Medicine

Volumn 57, Issue 4, 2016, Pages 568-573

  Scholtens, Asbjørn M ^a   Verberne, Hein J ^b   Budde, Ricardo P J ^c   Lam, Marnix G E H ^d  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiac glucose metabolism; Endocarditis; FDG PET; Heparin; Low carbohydrate diet; Sarcoidosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEPARIN; ANTICOAGULANT AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY SURFACE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE METABOLISM; HUMAN; LOW CARBOHYDRATE DIET; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; CARDIAC MUSCLE; DIET; DRUG EFFECTS; ENDOCARDITIS; FEMALE; HEART; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; NEOPLASM; PROCEDURES; SARCOIDOSIS; SCINTISCANNING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DIET; DIET, CARBOHYDRATE-RESTRICTED; ENDOCARDITIS; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART; HEPARIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIUM; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SARCOIDOSIS; YOUNG ADULT;

EID: 84963976816     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.166884     Document Type: Article

References (27)

1. 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med. 2014;28:393-403.
2. Schatka I, Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med. 2014;55:99-106.
3. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013;15:352.
4. 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374-2382.
5. 18F-FDG-PET fusion imaging for prosthetic heart valve endocarditis. JACC Cardiovasc Imaging. 2013;6:1008-1013.
6. Chen W, Kim J, Molchanova-Cook OP, Dilsizian V. The potential of FDG PET/ CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep. 2014;16:459.
7. Ploux S, Riviere A, Amraoui S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8:1478-1481.
8. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
9. Persson E, Nordenstrom J, Nilsson-Ehle P, Hagenfeldt L,Wahren J. Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment. Clin Physiol. 1990;10:573-583.
10. 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res. 2014;4:1-219X-4-1.
11. Soussan M, Brillet PY, Nunes H, et al. Clinical value of a high-fat and lowcarbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20:120-127.
12. Kobayashi A, Shinozaki T, Shinjyo Y, et al. FDG PET in the clinical evaluation of sarcoidosis with bone lesions. Ann Nucl Med. 2000;14:311-313.
13. 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity. Clin Nucl Med. 2013;38:128-130.
14. 18F-FDG uptake in patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20:1108-1115.
15. 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet. Eur Radiol. 2012;22:2221-2228.
16. 18F-FDG uptake during PET: a randomized controlled trial. J Nucl Cardiol. 2010;17:286-291.
17. 18F-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol. 2009;16:801-810.
18. 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR. 2008;190:W151-W156.
19. 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45:1989-1998.
20. Garfein O. Current Concepts in Cardiovascular Physiology. Burlington, Vermont: Elsevier Science; 1990:565.
21. Dávila-Román VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271-277.
22. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med. 1990; 31:1749-1756.
23. 18F FDG uptake at oncologic PET/CT. Radiographics. 2011;31:1287-1305.
24. 18FDG patterns seen in oncologic positron emission tomography computed tomography: importance for differentiating normal physiology from cardiac and paracardiac disease. J Thorac Imaging. 2012;27:263-268.
25. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a metaanalysis. Blood. 2005;106:2710-2715.
26. Sheikh IR, Ahmed SH, Mori N, et al. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in percutaneous peripheral intervention: a single-center experience. JACC Cardiovasc Interv. 2009;2:871-876.
27. Asmal AC, Leary WP, Thandroyen F, Botha J, Wattrus S. A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects. Br J Clin Pharmacol. 1979;7:531-533.